PFE Pfizer
- Official Name: PFIZER INC.
- Headquarters: 66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001-2192 US
- CEO: Albert Bourla
- Website: pfizer.com
- Key Investor: VANGUARD GROUP INC | 9.2%
- Dedicated Investor: PALACIOS WEALTH MANAGEMENT, LLC | 19.04%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-14 | 1 | Won by 1.971 | 0.917 - (1.054) | ||
| 2025-07-21 | 2 | Won by 1.966 | (2.791) - (4.757) | ||
| 2025-07-28 | 3 | Lost by 1.837 | 0.494 - 2.331 | ||
| 2025-07-29 | 2R | Won by 4.840 | (0.749) - (5.589) | ||
| 2025-08-04 | 4 | Won by 1.423 | (1.722) - (3.145) | ||
| 2025-08-07 | 1R | Won by 1.790 | 1.159 - (0.631) | ||
| 2025-08-11 | 5 | Won by 7.298 TOTW | 6.017 - (1.281) | ||
| 2025-08-12 | 3R | Lost by 2.060 | 0.127 - 2.187 | ||
| 2025-08-18 | 6 | Lost by 1.705 | 1.820 - 3.525 | ||
| 2025-08-20 | 1R | Won by 0.486 | 0.679 - 0.193 | ||
| 2025-08-21 | 2R | Won by 1.160 | 1.163 - 0.003 | ||
| 2025-08-25 | 7 | Lost by 1.016 | 0.920 - 1.936 | ||
| 2025-09-01 | 8 | Lost by 2.214 | (1.467) - 0.747 | ||
| 2025-09-03 | 2R | Won by 0.812 | (0.810) - (1.622) | ||
| 2025-09-04 | 3R | Lost by 2.913 | (1.015) - 1.898 | ||
| 2025-09-08 | 9 | Lost by 6.423 | (0.798) - 5.625 | ||
| 2025-09-15 | 10 | Won by 3.758 | (2.622) - (6.380) | ||
| 2025-09-17 | 3R | Lost by 0.438 | 0.677 - 1.115 | ||
| 2025-09-22 | 11 | Won by 0.018 | 0.282 - 0.264 | ||
| 2025-09-29 | 12 | Lost by 0.180 | (0.781) - (0.601) | ||
| 2025-10-06 | 13 | Won by 7.277 | 7.643 - 0.366 | ||
| 2025-10-13 | 14 | Lost by 0.987 | (6.206) - (5.219) | ||
| 2025-10-20 | 15 | Won by 3.954 | (0.081) - (4.035) |
Latest News

Stay informed about the most active stocks in the S&P500 index on Monday's session.
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Monday and uncover the stocks that ar...
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know

Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs
Big Pharma hits new 52-week highs on strong Q2 results; explore why some lag and which healthcare ETF offers best income risk/reward. Click for more a...

Take Two Interactive, Nvidia, Cheniere Energy And A Health Care Stock: CNBC’s ‘Final Trades’
Take-Two Interactive Software, on Aug. 7, reported adjusted earnings were 35 cents per share, topping the analyst consensus of 33 cents.

Dividend Champion, Contender, And Challenger Highlights: Week August 30
Dividend activity recap for Champions, Contenders & Challengers: dividend changes plus upcoming ex-dividend and pay dates. See more here.

BioNTech: Reiterating Strong Buy Based On COMIRNATY Variant Expansion And More
BioNTech SE maintains a Strong Buy rating, driven by robust late-stage oncology pipeline momentum and strategic partnerships. Click for more on BNTX.
Hesai Says Co Selected By NVIDIA As Lidar Partner For NVIDIA DRIVE Hyperion 10

QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax
FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligibility for adults 65+ and those with high-risk...
FDA Approves Pfizer And BioNTech's Supplemental Biologics License Application For 2026-2027 COVID-19 Vaccine Formula
2026-2027 COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closely match contemporary circulating variantsShipping ...